Stay updated on Darolutamide in Addition to ADT Clinical Trial
Sign up to get notified when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.

Latest updates to the Darolutamide in Addition to ADT Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe References section was removed from the study record page, and the list of cited sources is no longer displayed.SummaryDifference0.0%

- Check16 days agoChange DetectedA new history entry on 2026-02-06 adds a Study Status update with Revision: v3.4.2. The prior government funding notice (2026-01-14) has been removed (Revision: v3.4.1).SummaryDifference0.6%

- Check23 days agoChange DetectedThe page now displays a general government-funding notice and updates the site software revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check30 days agoChange DetectedAdded a glossary toggle and color-coded change indicators to explain edits in the record history. Revision notes now show 'No FEAR Act Data' and 'Revision: v3.4.0' with the previous 'Revision: v3.3.4' entry removed.SummaryDifference0.5%

- Check37 days agoChange DetectedNew revisions on 2026-01-14 add updated Contacts/Locations and Study Status for the record, reflecting current recruitment information and contact points. The history also includes a 2025-12-21 entry and removes the 2025-12-02 entry.SummaryDifference0.3%

- Check44 days agoChange DetectedThe revision history now shows an added Revision: v3.3.4 and a removed Revision: v3.3.3 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Darolutamide in Addition to ADT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Darolutamide in Addition to ADT Clinical Trial page.